Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Winding Up the Santa Monica Program: Dr. Goss on Implementing Molecular Markers Across Health Care Systems
Author
Howard (Jack) West, MD

This is the last of six podcasts produced from the two hour program we did in partnership with the LUNGevity Foundation earlier this year in Santa Monica, at the start of the "Targeted Therapies in Lung Cancer" annual meeting.  This activity was comprised of some great panel discussions and brief presentations on tough but timely issues on the subject of "Molecular Markers in Advanced NSCLC: Who to Test and What to Test For?".  It featured guest faculty members Dr. Charlie Rudin from Johns Hopkins University, Dr. Alice Shaw from Massachusetts General Hospital, Dr. David Spigel from Sarah Cannon Cancer Center, and Dr. Glen Goss from the University of Ottawa.  

In this last installment, Dr. Goss speaks on the topic of how to broaden the incorporation of molecular marker studies in lung cancer beyond specialty academic centers and try to implement them in wider networks.  He discusses the early pilot efforts as well as the challenges, particular cost issues, but raises the possibility that smarter treatment could also prove to be more cost-effective, even adding the cost of more and better molecular diagnostic studies.

We follow his presentations with some final meaty questions about the panels views on what role physicians should play in considering costs of health care recommendations, whether we should be doing "reflex testing" automatically for all patients with advanced NSCLC (or a defined subset), and whether there's a clear role and incentive for repeat biopsies over the course of ongoing treatment.

Here are the audio and video versions of the podcast, along with transcript and figures.

Molecular Markers SM Pt 6 Goss on Markers in HC Systems Audio Podcast

Molecular Markers SM Pt 6 Goss on Markers in HC Systems Transcript

Molecular Markers SM Pt 6 Goss on Markers in HC Systems Figs

 

Our next podcasts will cover presentations by Drs. Ramaswamy Govindan and Julie Brahmer on Immunotherapies for Lung Cancer.  There should be some news on this front from ASCO, particularly on anti-PD1 as a mechanism, so we'll work to get that content out around the time we're discussing the new information being presented at ASCO.  

 

 

 

 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.
Image
Rare cancers
Video
In these videos,  Dr. Jared Weiss gives a brief overview of NUT Carcinoma, discusses treatment options and possible future treatment.  To watch the complete playlist, click here.  
Article
Don't let the word "small" deceive you. Small cell lung cancer (SCLC) casts a long shadow, impacting lives with its aggressive nature and the complexities of its treatment. But while the challenges are real, so is the progress. Breakthroughs in small cell lung cancer treatment offer hope. Immunotherapy plus chemo-radiation improves survival by 22 months. Screening catches it early.

Forum Discussions

Can SCLC also be treated with targeted therapy?

Hi amitchouhan,

Welcome to Grace. At this time, there aren't any targeted therapies to treat SCLC, but there are new treatments. Check out our latest OncTalk webinar from December. The last...

I was searching for this, Thank you so much for the info.

Recent Comments

JOIN THE CONVERSATION
Yes, it's crucial to discuss…
By JanineT GRACE … on
Definitely a good idea to…
By OakleeFarnick on
Thank you for sharing
By LeviDrake on
Hi bluesun,I don't know of…
By JanineT GRACE … on